BioPharma Dive ٩ ديسمبر ٢٠٢٥ J&J’s ‘remarkable’ Tecvayli data support earlier use in multiple myeloma
BioPharma Dive ٨ ديسمبر ٢٠٢٥ Terns drug shows potential to challenge Novartis’ blockbuster leukemia treatment
BioPharma Dive ٨ ديسمبر ٢٠٢٥ Dyne to seek Duchenne drug approval; Kymera, Wave and Structure shares soar
BioPharma Dive ٥ ديسمبر ٢٠٢٥ Hemophilia gene therapies are struggling on the market, even as innovation soars
BioPharma Dive ٣ ديسمبر ٢٠٢٥ After finding ‘irregularities,’ Bristol Myers to extend key trial of Cobenfy in Alzheimer’s psychosis